Physician profile
Mustafa Arain
NPI 1669420618
$43,694.42
in general payments reported to CMS, 2019-2025
14 companies · $777 in 2025
The $777 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $1,704 · 2021: $16K · 2022: $968 · 2023: $4,217 · 2024: $380 · 2025: $777.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,383 · Food and Beverage: $1,991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,382.50 |
| Food and Beverage | $1,990.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $20,681.03 | 2019-2025 | Spyglass, General - Therapies, General - Biliary Devices |
| Medtronic, INC. | $14,837.98 | 2021-2025 | Gi Genius, Prodigi, Nexpowder |
| Olympus Corporation | $3,382.50 | 2023 | Evis Exera III Video System Center |
| Olympus Corporation of The Americas | $2,526.98 | 2019-2024 | Smartband Safegrip Multi-Band Ligation Kit, Gastrointestinal Videoscope, Long Clip |
| Cook Medical LLC | $665.12 | 2019-2025 | Echotip Insight, Echotip |
| Wilson Cook Medical Incorporated | $400.00 | 2020 | |
| Olympus America INC. | $328.32 | 2019-2025 | Evis Exera III Duodenovideoscope, Evis Exera Lll Colonovideoscope |
| Abbvie INC. | $234.32 | 2021-2025 | Creon |
| Apollo Endosurgery US INC | $149.56 | 2022 | |
| 3-D Matrix, INC. | $143.23 | 2024 | |
| Intercept Pharmaceuticals, INC. | $127.98 | 2023 | Ocaliva |
| Pentax of America, INC. | $108.85 | 2022 | |
| Amgen INC. | $58.30 | 2025 | Uplizna |
| Covidien LP | $50.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mustafa Arain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.